Abstract | BACKGROUND: OBJECTIVE: DESIGN: Cross-sectional analysis of manifestations of participants who were enrolled in treatment trials between December 1995 and December 2002. SETTING: Multicenter study in 63 clinical centers in France, Belgium, Latvia, and the United Kingdom, coordinated by the French Vasculitis Study Group. PARTICIPANTS: MEASUREMENTS: The authors compared principal demographic, clinical, and laboratory features according to ANCA status at diagnosis. RESULTS: LIMITATIONS: The authors assessed ANCA by immunofluorescence, but they did not assess ANCA centrally or systematically retest if ANCA was undetected at diagnosis. CONCLUSIONS:
|
Authors | Régis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, Christian Pagnoux, Luc Mouthon, David Jayne, Daniel Blockmans, Jean-François Cordier, Philippe Delaval, Xavier Puechal, Dominique Lauque, Jean-François Viallard, Abdelkader Zoulim, Loïc Guillevin, French Vasculitis Study Group |
Journal | Annals of internal medicine
(Ann Intern Med)
Vol. 143
Issue 9
Pg. 632-8
(Nov 01 2005)
ISSN: 1539-3704 [Electronic] United States |
PMID | 16263885
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Antineutrophil Cytoplasmic
|
Topics |
- Adolescent
- Adult
- Aged
- Antibodies, Antineutrophil Cytoplasmic
(immunology)
- Churg-Strauss Syndrome
(blood, complications, diagnosis)
- Cross-Sectional Studies
- Female
- Fever
(etiology)
- Heart Diseases
(etiology)
- Humans
- Kidney Diseases
(etiology)
- Male
- Middle Aged
- Peripheral Nervous System Diseases
(etiology)
- Prognosis
- Prospective Studies
- Severity of Illness Index
|